2-DG drug

2-deoxy-D-glucose (2DG) is a drug developed by a DRDO lab called Institute of Nuclear Medicine and Allied Science (INMAS) to be used for the COVID-19 treatment. It helps hasten COVID-19 patients’ recovery and reduces their supplemental oxygen dependence. This oral anti-COVID-19 drug accumulates in infected cells and curbs the energy supply to the virus, leading to the reduction of the viral infection. It received the approval of the Drugs Controller General of India (DGCI).